Finger-stick blood test may not help type 2 diabetes treatment

Image
IANS New York
Last Updated : Jun 11 2017 | 6:07 PM IST

New research has revealed that checking blood sugar with a finger-stick may not help type 2 diabetes patients who do not use insulin.

Type 2 diabetes is an epidemic afflicting one in 11 people in the US and for those treated with insulin, checking blood sugar with a finger-stick at home is an accepted practice for monitoring the effects of insulin therapy.

However, researchers from UNC School of Medicine found that the majority of type 2 diabetes patients are not treated with insulin.

"Our study results have the potential to transform current clinical practice for patients and their providers by placing a spotlight on the perennial question, 'to test or not to test'," said Katrina Donahue, Professor at UNC School of Medicine.

Most of the 25 million people with type 2 diabetes in US today do not take insulin but control their blood sugar with exercise, diet, and sometimes medications such as metformin.

Currently, 75 per cent of these patients also perform regular blood glucose testing at home, generally at the recommendation of a provider, despite an on-going debate about its effectiveness in controlling diabetes or improving how patients feel.

"Of course, patients and providers have to consider each unique situation as they determine whether home blood glucose monitoring is appropriate," Donahue said.

"But the study's null results suggest that self-monitoring of blood glucose in non-insulin treated type 2 diabetes has limited utility. For majority, the costs may outweigh the benefits," she added.

The study that involved 450 patients suggested that patients living with diabetes should discuss the need for blood sugar monitoring with their health care providers.

"If together a patient and their provider decide that blood sugar monitoring is not necessary, patients could be spared hundreds of finger sticks and save hundreds of dollars every year, at least until insulin treatment is required," the study published in the journal JAMA Internal Medicine noted.

Though proponents of blood glucose testing argue that daily testing promotes better awareness of glucose levels leading to improvements in diet and lifestyle, the research asserts that daily testing imposes not only a financial cost but can also take a mental toll, increasing the rate of depression or anxiety in some patients.

--IANS

qd/vgu/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 11 2017 | 5:58 PM IST

Next Story